We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Takara Bio USA and Hamilton Partner Partner to Automate NGS Library Preparation

By LabMedica International staff writers
Posted on 01 Apr 2026

Takara Bio USA, Inc. More...

(San Jose, CA, USA), a wholly owned subsidiary of Takara Bio Inc., and Hamilton Company (Reno, NV, USA) announced a development and co-marketing agreement to deliver integrated, automated next-generation sequencing (NGS) library preparation workflows to laboratories worldwide.

The collaboration focuses on verified automation methods for Takara Bio USA’s SMART-Seq library preparation kits on Hamilton’s Microlab STAR Liquid Handling Systems. The first automated technology will be the SMART-Seq mRNA LP kit, which streamlines the creation of full-length mRNA‑seq libraries. Automation script development is also slated for the SMART-Seq Total RNA Library Prep with ZapR Depletion kit.

By combining Takara Bio’s library preparation chemistry with Hamilton’s liquid-handling automation, the integrated workflows are designed to reduce hands-on time and errors while increasing throughput and lowering labor costs. The Microlab STAR platform and associated methods support scalable, end-to-end, assay-ready workflows. Verified, standardized protocols are intended to deliver consistent, reproducible library preparation and high-quality data for downstream sequencing and transcriptomic analyses.

The approach is positioned for laboratories and core facilities that require routine, high-capacity RNA‑seq operations. The collaboration is intended to enable use of full-length transcriptome analysis as a research tool or service on a standardized, high-throughput platform. Takara Bio USA is also a sponsor of the Association of Biomolecular Resource Facilities Annual Meeting in Pittsburgh, Pennsylvania, from March 28–31, 2026, where core facilities professionals can meet with company representatives.

“The automation of Takara Bio library prep kits allows laboratories, including core facilities, to use our trusted technology as a routine, high-throughput research tool or service,” said Carol Lou, President & CEO at Takara Bio USA. “We are thrilled to partner with Hamilton to enable large-scale full-length transcriptome analysis, launching our gold-standard SMART-Seq library prep workflows into an era of high consistency and efficiency provided by the Microlab STAR systems.”

“At Hamilton, our focus is enabling fully integrated, scalable workflows that bring consistency and efficiency to complex biological processes,” said Michael Mouradian, Vice President of Scientific Strategy and Market Development at Hamilton Company. “By partnering with Takara Bio, we are combining best-in-class library preparation chemistry with advanced liquid handling automation to help laboratories standardize RNA-seq workflows and accelerate the generation of high-quality data at scale.”

Related Links
Takara Bio
Hamilton Company


New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Multi-Chamber Washer-Disinfector
WD 390
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.